PIVKA-II is a useful tumor marker for recurrent hepatocellular carcinoma after surgical resection

Medicine and Dentistry

• Antagonist 100%
• Absence 50%
• Prothrombin 50%
• Hepatocellular Carcinoma 44%
• Alpha-Fetoprotein 38%
• Surgery 27%
• Patient 22%
• Measurement 11%
• Tumor Marker 11%
• Ethinylestradiol Plus Megestrol Acetate 11%
• Diagnosis 5%
• Recurrent Disease 5%
• Follow up 5%
• Cancer Diagnosis 5%
• Sensitivity and Specificity 5%
• Tumor Recurrence 5%
• Monitoring 5%
• Marker 5%
• Early Diagnosis 5%

Pharmacology, Toxicology and Pharmaceutical Science

• Prothrombin 50%
• Vitamin K Group 50%
• Absence 50%
• Liver Cell Carcinoma 44%
• Alpha Fetoprotein 38%
• Tumor Marker 11%
• Ethinylestradiol Plus Megestrol Acetate 11%
• Recurrent Disease 5%
• Tumor Recurrence 5%

Biochemistry, Genetics and Molecular Biology

• Vitamin K 50%
• Prothrombin 50%
• Alpha-Fetoprotein 38%
• Tumor Marker 11%